HEARN, Brian,SANTI, Daniel V.,FONTAINE, Shaun,ASHLEY, Gary W.
申请号：
AU2019208024
公开号：
AU2019208024A1
申请日:
2019.01.11
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Advantage is taken of the enhanced permeability and retention effect (EPR effect) to shield normal tissue from exposure to combinations of chemotherapeutic agents. Imaging agents that exhibit the enhanced permeability and retention (EPR) effect in solid tumors are useful in mimicking the behavior of chemotherapeutic or other drugs for treatment of said tumor conjugated to carriers of similar size and shape to the carriers of said imaging agents.
